Online and Social Media Advertising Rules for Food Supplements in Thailand

A registered supplement is only half the compliance picture in Thailand. The other half is how the product gets marketed once it is on the shelf, and Thai FDA treats advertising as a regulated activity in its own right, requiring prior approval before publication in any medium, online included. That obligation lands on the registration holder even when the advertisement was created by a distributor, retailer, or influencer the brand never directly instructed.

The legal basis behind advertising control

Supplement advertising in Thailand runs through Section 40 of the Food Act B.E. 2522 (1979), which prohibits food advertising containing false or misleading statements, or claiming that a food product can treat, prevent, or cure disease. Because supplements are regulated as food, every piece of supplement advertising has to comply with the Food Act's prohibitions plus the additional advertising standards Thai FDA issues under the Act.

The requirement goes beyond simply avoiding prohibited content: it requires the advertisement itself to be approved by Thai FDA before it runs. A brand cannot launch a campaign in Thailand until the specific advertising material has been submitted for review and an approval certificate issued for that exact piece of content, and the approval certificate number then has to appear on all printed materials.

This obligation sits with the registered importer or local product owner, not with the platform or media outlet that publishes the advertisement. If a distributor, retailer, or influencer publishes an unapproved ad for a registered supplement, the enforcement action, whether a fine or a registration suspension, targets the registration holder, not the publisher. A brand that does not actively control how its product is advertised in Thailand is carrying real exposure it may not know it has.

This is the part of the framework that catches multinational brands off guard most often, since their global marketing teams are used to a compliance model where the platform, not the brand, bears responsibility for policing content. In Thailand that assumption runs backward. A regional distributor running its own paid social campaign, or a local retailer posting product photos with health claims lifted from the brand's own international packaging, creates liability for the registration holder the moment that content goes live, whether or not the brand knew the post existed.

Where claims cross the line

Certain categories of claim are consistently refused, and understanding them before drafting creative saves the delay of a rejected submission. A claim that a supplement treats, prevents, alleviates, or cures a disease is absolutely prohibited, and Thai FDA reads this broadly: both direct claims ("reduces cancer risk," "treats diabetes") and indirect ones, such as promoting healthy blood sugar language specifically to a diabetic audience, fall inside the prohibition. Claims that would pass in other markets are regularly refused in Thailand for implying a therapeutic effect they were never meant to carry.

Exaggerated or unsubstantiated health benefit claims face the same scrutiny. Phrases like "boosts immunity," "burns fat," and "detoxifies the body" are consistently refused or held for substantiation, and the evidentiary bar Thai FDA sets for these popular marketing phrases is often higher than brands expect coming from less regulated markets.

Testimonials carry their own risk. A user testimonial describing a symptom resolving, or a condition improving, in a way that goes beyond the brand's own permitted claims makes the advertisement non-compliant, even if the brand's official messaging stayed within bounds. Managing this in user-generated content and review platforms is one of the harder ongoing tasks in online supplement marketing here.

Before-and-after imagery is treated the same way: images implying disease treatment or exaggerated body composition change are typically refused unless the claimed change is modest and paired with a statement that results depend on diet and exercise. Weight management brands accustomed to using this format internationally usually have to rework it substantially for the Thai market.

Why enforcement now runs through digital channels

Thai FDA actively monitors supplement advertising across Facebook, Instagram, TikTok, Lazada, Shopee, and brand-operated websites, using both automated keyword monitoring and manual review to catch content that violates the Food Act or lacks the required approval certificate. When it finds a violation, Thai FDA can issue take-down requests to platform operators under Thailand's Computer Crimes Act B.E. 2550, alongside opening enforcement proceedings against the registration holder directly. Major Thai e-commerce platforms cooperate quickly with these requests, which means a non-compliant listing can disappear on very short notice.

Influencer marketing gets no exception. If an influencer post constitutes an advertisement, which Thai FDA interprets broadly to include any paid or product-exchanged commercial promotion, that post needs the same prior approval and the same visible certificate number as any other advertisement. The paid partnership or gifted product disclosure required under Thailand's Consumer Protection Act is a separate obligation and does not substitute for Thai FDA's advertising approval.

The approval process itself

The advertising material has to be finalized in its intended format before submission, since Thai FDA reviews the specific version presented and any later change to approved material requires a fresh application. Content used in multiple formats, video, static image, text, needs a separate application for each format if the content differs between them.

Applications go through Thai FDA's e-Submission portal under the food and supplement advertising category, and each one needs the product's registration certificate, the draft advertising material in its final form, a Thai translation of any foreign-language content, and the supporting substantiation for any permitted health benefit claim being made. Review of a standard application typically takes up to 8 working days from the point Thai FDA accepts a complete application via the e-Submission system, with a faster 2-working-day track available for advertising content that makes no claims about the product's benefits, quality, or properties, and Thai FDA may query specific claims or request modifications before issuing the approval certificate.

Once approved, the certificate number has to be displayed on all printed advertising and, for online content, either included directly in the advertisement or made accessible via a clearly marked link where a platform's character limits make direct inclusion impractical. Audio-visual advertisements need the number in the visible text portion of the content, not just spoken.

Building this timeline into a campaign calendar matters more for supplement brands than it might for other categories, since the 8 working day review window (or 2 working days for no-claim content) sits before every new piece of creative can run, not just before the first one. A brand planning a seasonal push, a new claim rollout, or a rebrand needs to treat the Thai FDA advertising approval step as a fixed part of the production schedule, submitted well ahead of the intended launch date rather than squeezed in once the creative is already finished and the media buy is booked.

Advertising compliance is the part of a Thailand supplement launch that keeps generating exposure long after the product itself is registered, particularly once distributors and influencers are creating content the brand did not draft itself. DeeMED Consulting reviews supplement advertising materials before Thai FDA submission and helps clients structure distributor and influencer agreements so advertising compliance obligations sit with the right party from the start, tied to the same health claims and labeling standards that govern the product itself.